Herbal Monograph
Thyme
Thymus vulgaris L.
Lamiaceae
Nature's premier respiratory antimicrobial — a culinary herb with powerful therapeutic applications validated by European pharmacopeia.
Overview
Plant Description
Low-growing, aromatic, evergreen subshrub, 15-40 cm tall, with a woody, branching base and numerous erect to ascending herbaceous flowering stems. Stems quadrangular (characteristic of Lamiaceae), becoming woody at the base with age, densely pubescent with short, curved hairs. Leaves opposite, small, 3-8 mm long, 1-3 mm wide, linear-elliptic to ovate-lanceolate, sessile or short-petiolate, with revolute (rolled-under) margins. Leaf surface dark green above, grayish-white and tomentose beneath due to dense glandular trichomes that contain the essential oil. Leaves are strongly aromatic when crushed. Inflorescence a terminal, verticillaster-type spike with whorls of small flowers at the leaf axils. Flowers small, 3-6 mm long, bilabiate (two-lipped), pale lilac to purple or white. Calyx tubular, bilabiate, 3-4 mm long, with ciliate teeth. Corolla tubular, two-lipped; upper lip erect, notched; lower lip three-lobed. Four stamens, didynamous (two long, two short). Fruit consists of four smooth, ovoid nutlets (mericarps) approximately 0.5-0.8 mm in diameter.
Habitat
Native to the western Mediterranean region, from the Iberian Peninsula through southern France to southern Italy. Thrives in dry, rocky, calcareous soils in full sun. Naturally found in garrigue and maquis shrubland communities on limestone hillsides, at elevations from sea level to approximately 1500 m. Prefers well-drained, alkaline to neutral soils (pH 6.0-8.0) with low fertility. Drought-tolerant once established. Intolerant of waterlogged or heavy clay soils.
Distribution
Native to the western Mediterranean basin (southern Europe, from Spain to Italy). Widely naturalized and cultivated throughout temperate Europe, North Africa, western Asia, and North America. Major commercial producers include Spain, France, Morocco, Turkey, Egypt, Poland, and Albania. Also cultivated extensively in North America (particularly California and the Pacific Northwest) and parts of South America. Naturalized in parts of North America, particularly in dry, rocky habitats.
Parts Used
Aerial parts (Thymi herba -- leaves and flowering tops)
Preferred: Dried herb for infusion or tincture; fresh herb for culinary and some medicinal applications
The primary medicinal form recognized in the European Pharmacopoeia, German Commission E, and ESCOP monographs. Contains essential oil (1-2.5%), flavonoids, rosmarinic acid, and triterpenic acids. Used in infusions, tinctures, fluid extracts, and as the source material for essential oil distillation. The dried herb must contain not less than 12 mL/kg (1.2%) essential oil per the European Pharmacopoeia specification. Both fresh and dried herb are used medicinally, though dried herb is the pharmacopoeial standard.
Essential oil (Thymi aetheroleum)
Preferred: Diluted in carrier oil for topical use; in pharmaceutical preparations (cough syrups, lozenges); in aromatherapy diffusion
Steam-distilled essential oil from fresh or partially dried aerial parts. The thymol chemotype oil must contain 37-55% thymol per the European Pharmacopoeia. Also contains carvacrol, p-cymene, gamma-terpinene, and linalool. Used externally as an antimicrobial, in oral hygiene products, and in pharmaceutical preparations for coughs and bronchitis. The essential oil is SIGNIFICANTLY more concentrated and potent than the whole herb and requires careful dilution for safe use. Internal use of undiluted essential oil is contraindicated due to mucosal irritation and hepatotoxicity risk.
Key Constituents
Phenolic monoterpenes (primary bioactive volatile compounds)
Thymol and carvacrol are the primary pharmacologically active constituents responsible for thyme's antimicrobial, expectorant, and antispasmodic actions. Their mechanism of antimicrobial action -- disruption of microbial cell membrane integrity through interaction with the lipid bilayer -- is well-characterized and underlies thyme's traditional use as an antiseptic and preservative. The phenolic monoterpenes also stimulate ciliary beat frequency in respiratory epithelium and have a direct spasmolytic effect on bronchial smooth muscle, supporting the expectorant and antitussive indications. Marchese et al. 2016 provides a comprehensive review of thymol's antimicrobial properties.
Monoterpene hydrocarbons and other volatile compounds
The monoterpene hydrocarbons and alcohols contribute to the overall therapeutic profile through additive and synergistic effects with thymol and carvacrol. p-Cymene and gamma-terpinene are biosynthetic precursors to thymol and have independent, albeit milder, pharmacological activity. The essential oil as a whole is more active than isolated thymol, suggesting synergistic interactions among volatile components. Chemotype variation significantly affects the therapeutic profile: the thymol chemotype is the pharmacopoeial standard for medicinal use.
Phenolic acids and polyphenols
Rosmarinic acid is the principal non-volatile phenolic compound in thyme and a major contributor to the antioxidant and anti-inflammatory activity of aqueous extracts (infusions and decoctions). Unlike the volatile terpenes, rosmarinic acid is readily extracted into water, making it a key active constituent in thyme tea. It provides anti-inflammatory activity via inhibition of complement, COX, and LOX pathways, complementing the anti-inflammatory effects of thymol in volatile oil-containing preparations.
Flavonoids
Flavonoids contribute to thyme's antispasmodic, anti-inflammatory, and antioxidant activities. Luteolin and apigenin have well-characterized smooth muscle-relaxing effects that complement the spasmolytic activity of thymol. The flavonoid fraction works synergistically with the essential oil to produce the overall bronchospasmolytic effect that underpins thyme's use in cough and bronchitis. The total flavonoid content is a quality parameter in some pharmacopoeial standards.
Triterpenic acids
Triterpenic acids, particularly ursolic acid, are major non-volatile constituents of thyme that contribute to its anti-inflammatory and antioxidant activities. They are poorly soluble in water but well-extracted in alcoholic preparations (tinctures, fluid extracts). Their anti-inflammatory mechanism via COX-2 and NF-kB inhibition complements the volatile oil's activity. Ursolic acid has attracted independent pharmacological interest for its anticancer and metabolic effects.
Tannins and other constituents
Tannins provide the astringent action that contributes to thyme's efficacy as a gargle for pharyngitis and oral inflammation. They precipitate surface proteins on damaged mucous membranes, forming a protective layer that reduces irritation and inflammation. This astringent activity complements the antimicrobial action of the essential oil in topical oral and throat applications.
Herbal Actions
Kills or inhibits the growth of microorganisms
One of thyme's most extensively documented actions. Thymol and carvacrol demonstrate broad-spectrum antimicrobial activity against Gram-positive bacteria (Staphylococcus aureus, including MRSA strains; Streptococcus pyogenes), Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Helicobacter pylori), fungi (Candida albicans, dermatophytes), and some viruses. The mechanism involves disruption of microbial cell membrane integrity, leading to loss of membrane potential, leakage of intracellular contents, and cell death. Thymol also inhibits bacterial efflux pumps, potentially reducing antibiotic resistance. Clinical relevance is best established for respiratory tract infections and oral/pharyngeal infections where direct mucosal contact occurs.
[2, 8, 9]Promotes the discharge of mucus from the respiratory tract
Thyme is classified as a secretolytic and secretomotor expectorant. Thymol and the essential oil stimulate the serous glands of the respiratory mucosa, increasing the volume and reducing the viscosity of bronchial secretions, thereby facilitating expectoration. Thymol also increases ciliary beat frequency in respiratory epithelium, promoting mucociliary clearance. This dual mechanism -- increased secretion and enhanced transport -- underlies the well-established use in productive and non-productive coughs. German Commission E approved for symptoms of bronchitis and whooping cough. EMA traditional use registration for cough associated with the common cold.
[1, 2, 6]Relieves smooth muscle spasm
Thymol and the flavonoid constituents (particularly luteolin and apigenin) produce dose-dependent relaxation of bronchial and intestinal smooth muscle. The antispasmodic effect on bronchial smooth muscle is central to thyme's efficacy in spasmodic cough and whooping cough. Mechanism involves both calcium channel antagonism and direct muscle relaxation. In vitro studies demonstrate spasmolytic activity on isolated tracheal and intestinal smooth muscle preparations. The combination of antispasmodic and expectorant actions makes thyme particularly effective for cough -- it simultaneously relaxes bronchial spasm and promotes secretion clearance.
[1, 2, 12]Relieves intestinal gas and bloating
The volatile oil relaxes gastrointestinal smooth muscle, reduces intestinal spasm, and promotes the expulsion of gas. Traditional carminative use across European herbalism for flatulence, bloating, and dyspepsia. Often combined with other carminative herbs (fennel, anise, peppermint) in digestive formulations. The antispasmodic effect on intestinal smooth muscle is well-demonstrated in pharmacological studies.
[1, 12]Prevents or slows oxidative damage to cells
Thyme demonstrates significant antioxidant activity attributable to multiple constituents: thymol and carvacrol (phenolic monoterpenes), rosmarinic acid (phenolic acid), and flavonoids (luteolin, apigenin). Rosmarinic acid is particularly potent as an antioxidant in aqueous extracts. Thyme extracts inhibit lipid peroxidation and scavenge reactive oxygen species. The antioxidant activity supports the anti-inflammatory effects and contributes to the preservation of food (traditional culinary use as a preservative has a pharmacological basis).
[2, 10]Reduces inflammation
Multiple anti-inflammatory mechanisms: thymol inhibits COX-2 and NF-kB signaling; rosmarinic acid inhibits complement activation, COX, and LOX; ursolic acid suppresses NF-kB and pro-inflammatory cytokines; flavonoids inhibit mast cell degranulation. Anti-inflammatory activity demonstrated in vitro and in animal models. Clinical anti-inflammatory effect is most relevant in the context of respiratory mucosal inflammation (bronchitis, pharyngitis) and topical applications (oral inflammation, minor skin infections).
[8, 10]Promotes perspiration
Mild diaphoretic action when taken as a hot infusion. Traditional use at the onset of colds and flu to promote sweating and 'break a fever.' The warming, aromatic nature of thyme promotes peripheral vasodilation and perspiration. Often combined with elderflower and yarrow in traditional European diaphoretic formulas for febrile upper respiratory infections.
[12]Tightens and tones tissue, reduces secretions
Mild astringent action due to tannin content (3-7%). Contributes to the efficacy of thyme preparations used as gargles for sore throat and pharyngitis, and as mouthwashes for oral inflammation. The astringent effect tones and tightens inflamed mucous membranes, reducing secretion and inflammation.
[1, 2]Therapeutic Indications
Respiratory System
Acute bronchitis (cough with phlegm)
The primary and best-evidenced indication for thyme. German Commission E approved for symptoms of bronchitis and whooping cough. EMA traditional use registration for cough associated with the common cold. Kemmerich et al. 2006 RCT (n=361) demonstrated that a thyme-ivy combination (Bronchipret) reduced coughing fits by 68.7% compared to 47.6% for placebo over 11 days in acute bronchitis (P<0.0001). Kemmerich et al. 2006b (n=361) showed thyme-primrose combination significantly superior to placebo for acute bronchitis symptoms. The dual expectorant-antispasmodic mechanism is particularly effective: thyme simultaneously promotes secretion clearance and relaxes bronchial spasm.
[1, 2, 6, 7]Whooping cough (pertussis) and spasmodic cough
Commission E approved indication. Thyme has been a traditional specific for whooping cough in European herbalism for centuries. The antispasmodic effect on bronchial smooth muscle is central to its efficacy in paroxysmal, spasmodic cough. While no modern RCTs specifically address pertussis, the long-standing traditional use is supported by pharmacological evidence of bronchospasmolytic activity. The combination of antimicrobial (against Bordetella pertussis in vitro), antispasmodic, and expectorant actions provides a rational pharmacological basis. Used as infusion, syrup, or fluid extract.
[1, 2, 12]Upper respiratory tract infections (colds, pharyngitis, laryngitis)
Traditional use supported by antimicrobial activity against common respiratory pathogens and anti-inflammatory effects on respiratory mucosa. Used as a warm infusion for early-stage colds (diaphoretic effect), as a gargle for sore throat and pharyngitis (antimicrobial and astringent effects), and as a steam inhalation for nasal and sinus congestion. The EMA assessment recognizes traditional use for relief of cold symptoms. Often combined with elderflower, sage, or marshmallow root in traditional formulations.
[2, 12]Catarrh of the upper respiratory tract
Commission E approved indication for catarrhal conditions of the upper respiratory tract. Thyme's secretolytic and secretomotor actions thin viscous mucus and promote its clearance. Steam inhalation of thyme infusion or diluted thyme essential oil is a traditional remedy for nasal and sinus congestion.
[1, 2]Digestive System
Dyspepsia (indigestion), flatulence, and bloating
Traditional carminative use well-established across European herbalism. The volatile oil relaxes gastrointestinal smooth muscle and promotes peristalsis. Commission E included gastrointestinal complaints among approved indications. Used as an infusion before or after meals. Often combined with other carminatives (fennel, anise, peppermint) in digestive tea blends.
[1, 12]Gastrointestinal infections and dysbiosis
Thymol demonstrates in vitro activity against gastrointestinal pathogens including Helicobacter pylori, pathogenic E. coli, and Candida species. Traditional use for intestinal parasites and fungal overgrowth. Clinical evidence is limited to in vitro and animal studies. Thyme essential oil has been used in veterinary medicine for gastrointestinal infections. Clinical significance in human gastrointestinal infections requires further investigation.
[8, 9]Immune System
Immune support during acute infections
Traditional use as a general antimicrobial and immune-supporting herb during acute respiratory and gastrointestinal infections. The broad-spectrum antimicrobial activity reduces pathogen burden while the anti-inflammatory and antioxidant effects may support immune function. Rosmarinic acid has demonstrated immunomodulatory activity in vitro (complement inhibition, modulation of inflammatory mediators). Clinical evidence for direct immunomodulation is limited; the primary benefit is likely indirect through antimicrobial and anti-inflammatory actions.
[12]Skin / Integumentary
Minor skin infections and wounds
Thymol's potent antimicrobial activity supports topical use for minor skin infections, cuts, and abrasions. Diluted thyme essential oil or strong thyme infusion used as a wash for infected wounds in traditional practice. Thymol is effective against dermatophytes (Trichophyton, Microsporum, Epidermophyton species) supporting use in fungal skin infections (tinea). Essential oil must be properly diluted (1-2% in carrier oil) for topical application to avoid irritation.
[2, 8]Oral and pharyngeal inflammation (stomatitis, gingivitis, pharyngitis)
Commission E approved indication for inflammation of the mouth and throat. Thyme infusion or diluted tincture used as a mouthwash or gargle provides antimicrobial, anti-inflammatory, and astringent effects. Thymol is a key active ingredient in Listerine and other commercial antiseptic mouthwashes. Clinical evidence supports efficacy of thymol-containing mouthwashes for reducing plaque and gingivitis.
[1, 2]Energetics
Temperature
warm
Moisture
dry
Taste
Tissue States
cold/depression, damp/stagnation, damp/relaxation
Thyme is classified as warm and dry in traditional European humoral medicine, consistent with its aromatic, volatile oil-rich nature. Its warming and drying qualities make it particularly suited to cold, damp respiratory conditions characterized by copious, thin, watery mucus and spasmodic cough. In traditional energetic terms, thyme stimulates and moves stagnant fluids in the lungs and digestive tract, warms cold tissue states, and tones relaxed, boggy mucous membranes through its astringent component. It is contraindicated energetically in hot, dry conditions (dry, irritated, non-productive cough with scanty secretions). The aromatic pungency indicates its volatile oil content and dispersing, stimulating nature. Thyme is considered less hot than ginger or cayenne -- warming rather than truly hot -- making it suitable for moderate cold/damp states without excessive aggravation of heat.
Traditional Uses
Ancient Egyptian medicine
- Embalming agent -- thyme was used in the mummification process for its preservative and antimicrobial properties
- Fumigant and incense for purification of temples and sick rooms
"Thyme was among the herbs used by ancient Egyptians in the embalming process, dating to approximately 1600 BCE or earlier. The preservative properties of thymol (though not identified as such until the 19th century) made thyme an effective embalming agent. Thyme was also burned as incense for fumigation and ritual purification. References in the Ebers Papyrus (c. 1550 BCE) include aromatic herbs likely encompassing thyme or closely related species."
[11]
Greco-Roman medicine
- Respiratory remedy for coughs and chest congestion (Dioscorides)
- Digestive tonic and carminative for stomach complaints
- Vermifuge (antiparasitic) for intestinal worms
- External antiseptic for wounds and bites
- Fumigant burned in sick rooms to purify the air
- Symbol of courage and strength (thymos = courage in Greek)
"Dioscorides (De Materia Medica, c. 70 CE) described thyme as expectorant and useful for chest complaints, intestinal worms, and as a diuretic. He recommended it mixed with honey for respiratory conditions and as a gargle for sore throat. Pliny the Elder (Naturalis Historia, c. 77 CE) recommended thyme for respiratory complaints, epilepsy, and as an antidote to venomous bites. Galen classified thyme as hot and dry in the third degree. The Greek word 'thymos' (courage, spirit) is the etymological root of the plant name, reflecting its association with bravery -- Greek soldiers bathed in thyme water before battle, and Roman soldiers added thyme to their bathwater for vigor."
Medieval European herbalism
- Respiratory remedy for coughs, bronchitis, and chest congestion
- Plague preventive -- carried in posies and strewn on floors during epidemics
- Digestive aid for flatulence and intestinal discomfort
- External wound herb and antiseptic
- Hildegard of Bingen: recommended for skin conditions, respiratory problems, and general debility
- Culinary preservative for meat and dairy products
"Hildegard of Bingen (1098-1179) recommended thyme in her Physica for various conditions including skin eruptions, respiratory complaints, and intestinal parasites. During the Black Death (14th century) and subsequent plague outbreaks, thyme was a key ingredient in 'plague posies' and strewing herbs, used to fumigate houses and public spaces. The medieval Latin Regimen Sanitatis Salernitanum (School of Salerno, 12th-13th century) recommended thyme for respiratory and digestive complaints. Thyme was cultivated in monastic physic gardens throughout medieval Europe for its medicinal and culinary uses."
[11]
Arabian medicine (Unani/Islamic tradition)
- Respiratory remedy for cough and asthma
- Digestive stimulant and carminative
- Vermifuge for intestinal parasites
- Treatment of oral and dental conditions
- General tonic and strengthening agent
"Ibn Sina (Avicenna, 980-1037 CE) described thyme in the Canon of Medicine (Al-Qanun fi al-Tibb) as a warming, drying herb effective for chest complaints, coughs, and intestinal worms. He recommended it for strengthening the stomach, expelling wind, and as a general tonic. In Unani humoral medicine, thyme is classified as hot and dry in the third degree, making it appropriate for cold and moist conditions. Arabian physicians preserved and transmitted much of the Greco-Roman knowledge of thyme's medicinal properties, which later influenced medieval European herbalism through translations of Arabic medical texts."
[11]
European/Western Herbalism (post-Renaissance to modern)
- Primary respiratory herb for coughs, bronchitis, whooping cough, and asthma
- Antiseptic gargle for sore throats, tonsillitis, and laryngitis
- Carminative for digestive discomfort, flatulence, and colic
- Topical antiseptic for wounds, fungal infections, and skin conditions
- Anthelmintic (vermifuge) for intestinal parasites, particularly roundworms
- Ingredient in cough syrups, lozenges, and chest rubs
- Bath herb for rheumatic conditions and general debility
- Mouthwash ingredient for oral hygiene and gingivitis
"Nicholas Culpeper (Complete Herbal, 1653) recommended thyme as 'a notable strengthener of the lungs' and for whooping cough, shortness of breath, and other pulmonary complaints. Mrs. Grieve (A Modern Herbal, 1931) described thyme as antiseptic, antispasmodic, tonic, and carminative, with emphasis on its respiratory applications. The isolation of thymol in 1725 by Caspar Neumann and its subsequent identification as a powerful antiseptic by 1867 established the scientific basis for thyme's traditional antimicrobial use. Thymol was used as a surgical antiseptic before the widespread adoption of carbolic acid. In the 19th-20th century, thyme remained a mainstay of European pharmacies for cough preparations, culminating in the German Commission E positive monograph (1998) and EMA traditional use registrations."
Modern Research
Thyme-ivy combination (Bronchipret) for acute bronchitis: randomized controlled trial
Multicenter, double-blind, placebo-controlled RCT of 361 patients with acute bronchitis evaluating a fixed combination of thyme herb and ivy leaf fluid extract (Bronchipret) versus placebo over 11 days.
Findings: The thyme-ivy combination reduced coughing fits by 68.7% compared to 47.6% for placebo by day 11 (P<0.0001). Time to 50% reduction in coughing fits was significantly shorter in the treatment group (6 days vs. 8 days, P<0.0001). Bronchitis Severity Score improved significantly more in the treatment group. The preparation was well-tolerated with a safety profile comparable to placebo.
Limitations: Industry-funded study (Bionorica SE). Single combination product tested, making it difficult to attribute effects to thyme alone vs. the thyme-ivy combination. 11-day treatment duration. Self-reported outcome measures for coughing frequency.
[6]
Thyme-primrose combination for acute bronchitis: randomized controlled trial
Multicenter, double-blind, placebo-controlled RCT of 361 outpatients with acute bronchitis evaluating a fixed thyme-primrose root combination versus placebo over 11 days.
Findings: Patients in the thyme-primrose group showed a significantly greater reduction in coughing frequency compared to placebo. Time to 50% reduction in coughing fits was 7 days in the treatment group versus 9 days in the placebo group (P<0.0001). The Bronchitis Severity Score decreased significantly more in the treatment group. Good tolerability with no serious adverse events attributed to treatment.
Limitations: Industry-funded (Bionorica SE). Same limitations as the thyme-ivy trial: combination product, self-reported outcomes, relatively short duration. Cannot determine the individual contribution of thyme vs. primrose root.
[7]
Antimicrobial properties of thymol: comprehensive review
Comprehensive review of the antimicrobial activity of thymol, evaluating in vitro and in vivo evidence against bacteria, fungi, and parasites, including mechanisms of action.
Findings: Thymol demonstrates potent broad-spectrum antimicrobial activity. MIC values against common pathogens: S. aureus 0.031-0.5 mg/mL, E. coli 0.05-0.5 mg/mL, C. albicans 0.015-0.5 mg/mL. Mechanism of action primarily involves disruption of cell membrane integrity through interaction with the lipid bilayer, increasing permeability and causing leakage of intracellular contents (K+, ATP, nucleic acids). Thymol also inhibits bacterial biofilm formation and efflux pump activity. Synergistic effects observed with conventional antibiotics. Activity against drug-resistant organisms (MRSA, VRE) at achievable concentrations.
Limitations: Most evidence is from in vitro studies. MIC values vary widely depending on methodology, bacterial strain, and growth conditions. In vivo antimicrobial concentrations at tissue level after oral administration are not well-characterized. Clinical translation of in vitro antimicrobial data to therapeutic efficacy in human infections requires further study.
[8]
In vitro antimicrobial activity of thyme oil against Helicobacter pylori
In vitro study evaluating the antimicrobial activity of thyme essential oil and thymol against Helicobacter pylori, the primary causative agent of peptic ulcer disease and gastric cancer.
Findings: Thyme essential oil and thymol demonstrated significant inhibitory activity against H. pylori clinical isolates. Both thymol-rich thyme oil and isolated thymol showed bactericidal activity at achievable concentrations. Activity was maintained across multiple H. pylori strains including metronidazole-resistant isolates.
Limitations: In vitro study only. Gastric bioavailability and in vivo efficacy against H. pylori colonization not established. The acidic gastric environment may affect thymol stability and activity. Not a substitute for established H. pylori eradication therapy.
[9]
Anti-inflammatory activity of Thymus vulgaris: in vivo evaluation
Animal study evaluating the anti-inflammatory activity of Thymus vulgaris essential oil and its major constituents in experimental inflammation models.
Findings: Thyme essential oil demonstrated significant dose-dependent anti-inflammatory activity in carrageenan-induced paw edema and pleurisy models. The anti-inflammatory effect was comparable to the reference drug indomethacin at higher doses. Individual constituents (thymol, carvacrol) also showed significant anti-inflammatory activity. Mechanism involved reduction of pro-inflammatory mediators including PGE2, TNF-alpha, and IL-1beta. Rosmarinic acid from thyme aqueous extract contributed additional anti-inflammatory activity through complement inhibition.
Limitations: Animal model data; direct translation to human clinical outcomes is uncertain. Doses used in animal models may not reflect achievable concentrations from standard human doses. Further clinical studies in humans are needed.
[10]
EMA/HMPC assessment report on Thymus vulgaris L. and Thymus zygis L., herba
Comprehensive regulatory assessment by the European Medicines Agency Committee on Herbal Medicinal Products, evaluating the clinical and non-clinical evidence supporting the traditional medicinal use of thyme herb.
Findings: The HMPC concluded that thyme herb preparations meet the criteria for traditional herbal medicinal product registration for: (1) relief of cough associated with the common cold (well-established use and traditional use), and (2) traditional use for relief of symptoms related to colds of the upper respiratory tract. Preparations include comminuted herbal substance for tea, liquid extracts, dry extracts, and tinctures. Adequate safety data supports the traditional use at recommended doses. The assessment recognized the clinical evidence from the Bronchipret trials (thyme combinations) and the extensive traditional use documented over more than 30 years.
Limitations: Regulatory assessment, not an independent systematic review. Traditional use registrations are based on plausibility and long-standing use rather than the level of clinical evidence required for well-established use licensing. The assessment acknowledged that more clinical data on thyme monotherapy (rather than combination products) would be valuable.
[2]
Preparations & Dosage
Infusion (Tea)
Strength: 1.5-2 g dried herb per 150-250 mL water
Steep 1.5-2 g (approximately 1-2 teaspoons) of dried thyme herb (Thymi herba) in 150-250 mL of just-boiled water for 10-15 minutes, covered to prevent loss of volatile oils. Strain and drink warm. May add honey for palatability and additional demulcent effect on sore throats.
1 cup (150-250 mL), 3-4 times daily
3-4 times daily for respiratory infections; 2-3 times daily for digestive complaints; as needed for gargling
Acute respiratory infections: 7-14 days or until symptoms resolve. May be used regularly as a health-maintaining tea.
Children 4-12 years: half adult dose (0.75-1 g per cup), 2-3 times daily. Children 1-4 years: quarter adult dose. Consult practitioner for children under 1 year.
The most common traditional preparation and the standard form described in the European Pharmacopoeia, Commission E, and EMA monographs. Covering the cup during steeping is essential to retain volatile oils. For use as a gargle (pharyngitis, tonsillitis), prepare at double strength (3-4 g per 150 mL), allow to cool to a comfortable temperature, and gargle for 30-60 seconds before spitting out. Fresh thyme can also be used at approximately 3-4 g per cup (fresh herb has higher water content).
Tincture
Strength: 1:5, 70% ethanol
Macerate dried thyme herb in 70% ethanol at a ratio of 1:5 for 2-4 weeks. Shake daily. Press and filter through muslin or coffee filter. Store in amber glass bottles.
2-6 mL (approximately 40-120 drops), 3 times daily
3 times daily for acute respiratory infections; 2-3 times daily for digestive complaints
Acute conditions: 7-14 days. Short-term use preferred.
Not generally recommended for children due to alcohol content. Glycerite may be substituted.
Tincture extracts both volatile oil components (thymol, carvacrol) and non-volatile constituents (rosmarinic acid, flavonoids, ursolic acid, tannins). The relatively high alcohol percentage (70%) is necessary for adequate extraction of the lipophilic terpenoids. Can be added to warm (not boiling) water before taking, which allows some alcohol to evaporate. Often used in combination tincture formulas for respiratory infections, paired with herbs such as elecampane, marshmallow root, or licorice.
[12]
fluid-extract
Strength: 1:1 fluid extract in ethanol-water
Commercially prepared fluid extract (1:1) of thyme herb in ethanol-water solvent. Standardized products are available with defined thymol content.
1-2 mL, 3 times daily
3 times daily
Acute respiratory conditions: 7-14 days
Consult practitioner. Reduced doses may be appropriate for older children.
More concentrated than tincture. The fluid extract is the form used in several commercial thyme cough preparations in Europe (e.g., as a component in Bronchipret). Standardized fluid extracts with defined thymol content provide more consistent dosing. Often combined with ivy leaf (Hedera helix) or primrose root (Primula veris) fluid extracts in commercial cough preparations.
Syrup
Strength: Strong thyme infusion (approximately 6-10%) with equal volume honey/sugar
Prepare a strong infusion or decoction of thyme (approximately 30-50 g dried thyme per 500 mL water). Strain thoroughly. Add an equal volume of honey or sugar (1:1 ratio by volume). Gently warm and stir until dissolved. Do not boil after adding honey to preserve enzymatic activity. Store refrigerated in a clean glass bottle.
1-2 teaspoons (5-10 mL), 3-4 times daily
3-4 times daily for cough, or as needed for sore throat
Acute respiratory infections: 7-14 days
Children 4-12 years: 1/2-1 teaspoon, 3 times daily. Children 1-4 years: 1/4-1/2 teaspoon, 2-3 times daily. Do not give honey-based syrups to children under 1 year (botulism risk).
A palatable and effective preparation particularly useful for children and for cough. Honey provides additional demulcent, antimicrobial, and cough-suppressing properties (honey itself has evidence as a cough remedy). The sugar/honey also acts as a preservative. Refrigerated shelf life approximately 2-4 weeks. Commercial thyme syrups are widely available in European pharmacies. One of the most traditional forms for respiratory use.
Essential Oil
Strength: Pure steam-distilled essential oil (thymol chemotype: 37-55% thymol per European Pharmacopoeia)
Steam-distilled essential oil of Thymus vulgaris (thymol chemotype). FOR EXTERNAL USE ONLY unless under qualified practitioner supervision. Topical: dilute 1-2% in carrier oil (2-4 drops per 10 mL carrier oil). Steam inhalation: add 3-5 drops to a bowl of hot water, cover head with towel, inhale for 5-10 minutes. Chest rub: 2-3% in carrier oil applied to chest and upper back. Diffuser: 3-5 drops.
Topical: 1-2% dilution in carrier oil. Steam inhalation: 3-5 drops in hot water. NOT for internal use without professional guidance.
Topical: 2-3 times daily. Steam inhalation: 1-3 times daily during acute respiratory infections.
As needed for acute conditions. Discontinue if skin irritation develops.
Children over 6: steam inhalation with 1-2 drops only, under supervision. Topical: 0.5-1% dilution. NOT for children under 6 due to risk of laryngospasm from strong aromatic oils. NOT for internal use in children.
CAUTION: Thyme essential oil (thymol chemotype) is one of the most potent antimicrobial essential oils but also one of the most irritating. NEVER apply undiluted to skin or mucous membranes. NEVER ingest undiluted essential oil -- thymol is hepatotoxic and caustic to mucous membranes at concentrated doses. The linalool chemotype is gentler and may be preferred for aromatherapy and children's topical applications. Always perform a patch test before topical use. Store away from children. For internal use, only enteric-coated capsules of thyme essential oil formulated by qualified manufacturers should be considered, and only under practitioner supervision.
gargle
Strength: Double-strength infusion (3-4 g per 150 mL) or diluted tincture (5-10 mL per 100 mL water)
Prepare a double-strength infusion: steep 3-4 g dried thyme in 150 mL of just-boiled water, covered, for 15 minutes. Strain and allow to cool to a comfortable temperature. Gargle for 30-60 seconds, then spit out. Alternatively, dilute 5-10 mL of thyme tincture in 100 mL of warm water for gargling.
Gargle 3-5 times daily during acute pharyngitis or oral inflammation
3-5 times daily during acute pharyngeal or oral inflammation
Continue until symptoms resolve, typically 5-10 days
Children over 6 who can gargle safely: same preparation, 2-3 times daily. Not for young children who cannot gargle reliably.
Commission E approved for inflammation of the mouth and throat. The gargle provides direct antimicrobial, anti-inflammatory, and astringent contact with pharyngeal and oral mucosa. Particularly effective for bacterial pharyngitis, tonsillitis, and gingivitis. Can be alternated with sage gargle for additional benefit. Do not swallow large amounts of the gargle solution.
Poultice
Strength: Strong thyme infusion or paste of powdered herb
Prepare a warm compress: soak a clean cloth in a strong, hot thyme infusion (30-50 g dried thyme per 500 mL water, steeped 15 minutes). Wring out and apply to the chest for respiratory conditions or to affected skin areas for infections. Alternatively, mix dried thyme powder with enough warm water to form a paste, spread on muslin, and apply.
Apply to affected area for 15-30 minutes
2-3 times daily as needed
Continue as needed for symptom relief. Discontinue if skin irritation develops.
Use with caution; test on small area first. Reduce application time to 10-15 minutes.
Traditional external application for chest congestion (applied over sternum and upper chest) and for minor skin infections and wounds. The warming effect promotes local circulation while the antimicrobial constituents provide topical antiseptic action. Not for use on open wounds or severely broken skin without practitioner guidance.
[12]
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Cross-reactivity with other Lamiaceae members (oregano, rosemary, sage, mint, basil, lavender) is possible due to shared chemical constituents. Allergic reactions are rare but documented and include contact dermatitis and, very rarely, respiratory hypersensitivity. Individuals with known Lamiaceae allergy should avoid thyme preparations.
Thyme essential oil (especially thymol chemotype) is toxic if ingested undiluted. Thymol is caustic to mucous membranes and hepatotoxic at concentrated doses. Symptoms of essential oil ingestion include severe nausea, vomiting, gastric pain, headache, dizziness, convulsions, and potentially coma and cardiac/respiratory arrest. Even small amounts (10-20 mL) of undiluted thymol-rich essential oil can be dangerous. This contraindication applies specifically to the concentrated essential oil, NOT to the whole herb or standard herbal preparations (infusions, tinctures) which contain the essential oil at safe, dilute levels.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Anticoagulants (warfarin, heparin) and antiplatelet agents (Anticoagulants/Antiplatelets) | theoretical | Thyme contains small amounts of vitamin K, and thymol has shown mild antiplatelet activity in vitro. However, the amounts of vitamin K in culinary thyme are minimal, and the antiplatelet effect has not been demonstrated clinically at standard therapeutic doses of whole herb preparations. |
| Thyroid medications (levothyroxine) (Thyroid hormones) | theoretical | Some in vitro and animal studies suggest that thyme extracts may influence thyroid hormone levels, though the evidence is inconsistent and the mechanism is unclear. Not confirmed in human studies. |
Pregnancy & Lactation
Pregnancy
caution therapeutic
Lactation
likely safe
Pregnancy: Thyme is considered safe as a culinary herb in normal food quantities during pregnancy. However, therapeutic doses (concentrated extracts, tinctures, large amounts of infusion) should be used with caution during pregnancy. Traditional reports attribute emmenagogue (menstruation-promoting) activity to thyme at high doses, and theoretical uterotonic effects have been postulated. The EMA assessment states that safety during pregnancy has not been established for medicinal use, and recommends that use during pregnancy is not recommended due to insufficient data. There are no modern clinical reports of adverse pregnancy outcomes from therapeutic thyme use, but the precautionary principle applies given the lack of safety data. Lactation: Safe as a culinary herb. In many traditional cultures, thyme is used as a food spice during breastfeeding without reported adverse effects. Insufficient data exist for therapeutic doses during lactation. Thymol is lipophilic and may pass into breast milk. A conservative approach suggests using standard culinary amounts rather than concentrated medicinal preparations during breastfeeding.
Adverse Effects
References
Monograph Sources
- [1] German Commission E (Bundesinstitut fur Arzneimittel und Medizinprodukte). Commission E Monograph: Thymi herba (Thyme) -- Positive. Bundesanzeiger (Federal Gazette) (1998)
- [2] Committee on Herbal Medicinal Products (HMPC), European Medicines Agency. Assessment report on Thymus vulgaris L., Thymus zygis L., herba. European Medicines Agency, EMA/HMPC/342334/2013 (2013)
- [3] World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 2: Herba Thymi. World Health Organization, Geneva (2004) : 259-269
- [4] European Scientific Cooperative on Phytotherapy (ESCOP). ESCOP Monographs: Thymi herba -- Thyme. ESCOP Monographs, 2nd edition. Thieme, Stuttgart (2003)
- [5] National Center for Complementary and Integrative Health (NCCIH). Thyme. NCCIH, National Institutes of Health (2020)
Clinical Studies
- [6] Kemmerich B, Eberhardt R, Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. Arzneimittelforschung (2006) ; 56 : 652-660 . DOI: 10.1055/s-0031-1296767 . PMID: 17063641
- [7] Kemmerich B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. Arzneimittelforschung (2006) ; 56 : 574-581 . DOI: 10.1055/s-0031-1296759 . PMID: 17063645
- [8] Marchese A, Orhan IE, Daglia M, Barbieri R, Di Lorenzo A, Ferrara L, Nabavi SM, Tacchini M, Ferroni C, Ferrara F. Antibacterial and antifungal activities of thymol: a brief review of the literature. Food Chem (2016) ; 210 : 402-414 . DOI: 10.1016/j.foodchem.2016.04.111 . PMID: 27211664
- [9] Nzeako BC, Al-Kharousi ZS, Al-Mahrooqui Z. Antimicrobial activities of clove and thyme extracts. Sultan Qaboos Univ Med J (2006) ; 6 : 33-39 . PMID: 21748125
- [10] Fachini-Queiroz FC, Kummer R, Estevao-Silva CF, Carvalho MD, Cunha JM, Grespan R, Bersani-Amado CA, Cuman RK. Effects of thymol and carvacrol, constituents of Thymus vulgaris L. essential oil, on the inflammatory response. Evid Based Complement Alternat Med (2012) ; 2012 : 657026 . DOI: 10.1155/2012/657026 . PMID: 22919415
Traditional Texts
- [11] Stahl-Biskup E, Saez F (eds). Thyme: The Genus Thymus (Medicinal and Aromatic Plants -- Industrial Profiles). Taylor & Francis, London (2002)
- [12] Bone K, Mills S. Principles and Practice of Phytotherapy: Modern Herbal Medicine (2nd edition). Churchill Livingstone/Elsevier (2013)
- [13] Tisserand R, Young R. Essential Oil Safety: A Guide for Health Care Professionals (2nd edition). Churchill Livingstone/Elsevier (2014)
Pharmacopeias & Reviews
- [14] European Pharmacopoeia Commission. European Pharmacopoeia, 10th Edition: Thymi herba (Thyme) and Thymi aetheroleum (Thyme Oil). Council of Europe, Strasbourg (2020)
Last updated: 2026-02-26 | Status: review